MEDFX | MEDGX | MEDFX / MEDGX | |
Total Expense Ratio | 1.06 | 0.81 | 131% |
Annual Report Gross Expense Ratio | 1.07 | 0.82 | 130% |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 2.687 | 2.794 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.11B | 7.11B | 100% |
Annual Yield % from dividends | 6.44 | 6.69 | 96% |
Returns for 1 year | 6.95 | 7.31 | 95% |
Returns for 3 years | 18.98 | 19.88 | 95% |
Returns for 5 years | 10.04 | 11.52 | 87% |
Returns for 10 years | 35.39 | 38.84 | 91% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSFRX | 22.63 | 0.38 | +1.71% |
Federated Hermes Clover Small Value R | |||
FGINX | 15.51 | 0.21 | +1.37% |
Macquarie Growth and Income A | |||
MXLSX | 36.60 | 0.48 | +1.33% |
Empower Small Cap Value Inv | |||
FSZIX | 9.79 | 0.01 | +0.10% |
Fidelity Advisor Sustainable EM Eq I | |||
DISRX | 24.03 | N/A | N/A |
BNY Mellon International Stock Fund I |